ANNE GOLDBERG: Open Payments
NPI 1538836044 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 35 payments from 6 companies in 2025. Trend: 2023 $885 · 2024 $553 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $347 |
| Alnylam Pharmaceuticals Inc. | 4 | $113 |
| BridgeBio Pharma, Inc. | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| SCPHARMACEUTICALS INC. | 1 | $27 |
Products named: LEQVIO, AMVUTTRA, Attruby, JARDIANCE, WINREVAIR, FUROSCIX, VERQUVO.
Industry payments across NY — which companies pay providers there.
